Pfizer says Covid treatment Paxlovid fails to prevent same-household infections
But the safety data in the trial was consistent with previous studies, which had shown the pills to be nearly 90% effective at preventing hospitalisation or death in Covid patients at high risk of severe illness.
Pfizer to conduct trials of antiviral Covid pill in Russia
The trials conducted on 90 people located in home-like conditions with someone who has symptomatic Covid-19 began on Nov 12 and will continue until March 2023.
Pfizer says anti-viral pill cuts risk of severe Covid by 89%
Results for Pfizer's experimental anti-viral pill appear to surpass those seen with Merck & Co Inc's pill molnupiravir.
Britain approves Merck’s Covid-19 pill in world first
It will be administered as soon as possible following a positive Covid-19 test and within five days of the onset of symptoms.
Merck Covid-19 pill sparks calls for access for lower income countries
The US has already locked up 1.7 million courses with an option for 3.5 million more by January of 2023 at about US$700 per course.
British launch hunt for pills to treat Covid-19 at home
British PM says he hopes pills or capsules can be available by the autumn to help fight a widely anticipated third wave.
No articles found.
